189 related articles for article (PubMed ID: 20939399)
21. Hepatitis D: clinical features and therapy.
Rizzetto M
Dig Dis; 2010; 28(1):139-43. PubMed ID: 20460902
[TBL] [Abstract][Full Text] [Related]
22. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation.
Borghesio E; Rosina F; Smedile A; Lagget M; Niro MG; Marinucci G; Rizzetto M
Hepatology; 1998 Mar; 27(3):873-6. PubMed ID: 9500721
[TBL] [Abstract][Full Text] [Related]
23. [Role of the hepatitis Delta virus on the pathogenesis of hepatic cirrhosis and hepatocellular carcinoma. Recent advances].
Romeo R
Recenti Prog Med; 2010 Feb; 101(2):52-6. PubMed ID: 20433000
[TBL] [Abstract][Full Text] [Related]
24. HDV evolution-will viral resistance be an issue in HDV infection?
Tabernero D; Cortese MF; Buti M; Rodriguez-Frias F
Curr Opin Virol; 2018 Oct; 32():100-107. PubMed ID: 30415162
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis delta and HIV infection.
Calle Serrano B; Manns MP; Wedemeyer H
Semin Liver Dis; 2012 May; 32(2):120-9. PubMed ID: 22760651
[TBL] [Abstract][Full Text] [Related]
26. Virological and clinical characteristics of delta hepatitis in Central Europe.
Heidrich B; Deterding K; Tillmann HL; Raupach R; Manns MP; Wedemeyer H
J Viral Hepat; 2009 Dec; 16(12):883-94. PubMed ID: 19566789
[TBL] [Abstract][Full Text] [Related]
27. Antiviral treatment with pegylated interferon and clinical outcomes in a cohort of immigrants patients affected by hepatitis delta: A retrospective analysis.
Boglione L; Lupia T; Cariti G; Ghisetti V; Milia MG; Burdino E; Di Perri G
J Med Virol; 2019 Jul; 91(7):1329-1334. PubMed ID: 30794324
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
29. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
[TBL] [Abstract][Full Text] [Related]
30. Natural course and treatment of hepatitis D virus infection.
Hsieh TH; Liu CJ; Chen DS; Chen PJ
J Formos Med Assoc; 2006 Nov; 105(11):869-81. PubMed ID: 17098688
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
[TBL] [Abstract][Full Text] [Related]
32. Origin of hepatitis delta virus.
Taylor J; Pelchat M
Future Microbiol; 2010 Mar; 5(3):393-402. PubMed ID: 20210550
[TBL] [Abstract][Full Text] [Related]
33. Viral hepatitis: how to manage type C and D infections.
Najm W
Geriatrics; 1997 May; 52(5):28-30, 33-4, 37. PubMed ID: 9152216
[TBL] [Abstract][Full Text] [Related]
34. Can We Predict Sustained Virologic Response to Interferon α Therapy in Patients With Chronic Hepatitis Delta Virus Infection?
Scholtès C; Kumar R; Zoulim F
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2350-2. PubMed ID: 26254201
[No Abstract] [Full Text] [Related]
35. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
36. Clinical features of hepatitis D.
Farci P; Niro GA
Semin Liver Dis; 2012 Aug; 32(3):228-36. PubMed ID: 22932971
[TBL] [Abstract][Full Text] [Related]
37. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b.
Erhardt A; Gerlich W; Starke C; Wend U; Donner A; Sagir A; Heintges T; Häussinger D
Liver Int; 2006 Sep; 26(7):805-10. PubMed ID: 16911462
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin.
Levast M; Larrat S; Thelu MA; Nicod S; Plages A; Cheveau A; Zarski JP; Seigneurin JM; Morand P; Leroy V
J Med Virol; 2010 May; 82(5):747-54. PubMed ID: 20336715
[TBL] [Abstract][Full Text] [Related]
39. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
[TBL] [Abstract][Full Text] [Related]
40. HBV/HDV Coinfection: A Challenge for Therapeutics.
Koh C; Da BL; Glenn JS
Clin Liver Dis; 2019 Aug; 23(3):557-572. PubMed ID: 31266627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
